Skip to main content Skip to section navigation Skip to footer
Investor Relations
Back to lenz-tx.com
LENZ Therapeutics, Inc. IR Home
  • Overview
  • News & Events
  • Company Info
  • Financial Results
  • Stock Data
  • SEC Filings
  • Governance
  • Back to lenz-tx.com

Media

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
  • Media
Aug 30, 2024

LENZ Therapeutics - NASDAQ Bell Ring

Aug 19, 2024

We Await the Fate of a New Presbyopia Drop - Significant Findings

Aug 14, 2024

Lenz Therapeutics Submits NDA for Presbyopia Eye Drop

Jun 4, 2024

Aceclidine, a Pupil-Selective Miotic, Demonstrates Positive Topline Data in Phase 3 Presbyopia Trials

rss_feed RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2025 LENZ Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences